Sat.Jan 20, 2024 - Fri.Jan 26, 2024

article thumbnail

Five retail pharmacy trends for 2024

Drug Store News

Labor challenges, the expansion of healthcare services, store-count rationalization and PBM reform are among the front-burner issues in the year ahead.

128
128
article thumbnail

Pharmacists Are Transforming and Optimizing HIV Treatment

Pharmacy Times

Regardless of a pharmacist’s practice site or type, they play an integral role in ensuring the treatment success of patients with HIV.

162
162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Who are the 50 most influential leaders in pharmacy?

Drug Store News

The Pharmacy 50 program, launched in 2021 by The Pharmacy Podcast Network, is recognizing individuals that have had a significant impact on the accomplishments of others in pharmacy.

116
116
article thumbnail

Pharmacy Focus: Policy Edition - PBM Audits

Pharmacy Times

On this episode, Dae Lee, Pharm.D., Esq., CPBS , and Harini Bupathi, Esq, attorneys at Frier Levitt, engage in a thought-provoking conversation on the evolving landscape of pharmacy benefit manager (PBM) audit strategies, regulations, and enforcement.

139
139
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vision for consultant pharmacists by 2030 unveiled by RPS

Hospital Pharmacy Europe

An ‘ambitious and exciting’ vision for consultant pharmacists to be leaders within the profession has been published by the Royal Pharmaceutical Society (RPS). The vision sets out a multifaceted approach under five strategic pillars to help to ensure consultant pharmacists are an integral part of the pharmacy and wider healthcare team in all sectors of the UK by 2030.

article thumbnail

Bipartisan Lawmakers Signal Support for H.R. 1770

Drug Topics

The Equitable Community Access to Pharmacist Services Act seeks to ensure that seniors in rural and underserved communities have access to care and services from pharmacists for common infectious diseases.

224
224

More Trending

article thumbnail

Advise Patients On Five Tips When Consuming Vitamins, Supplements, Energy Drinks

Pharmacy Times

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

article thumbnail

FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe

Fierce Pharma

As many have feared, the FDA’s investigation into secondary T-cell cancers following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning. | As many have feared, the FDA's investigation into secondary T-cell malignancies following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning.

FDA 141
article thumbnail

T2D Remission Through Weight Loss Linked With Lower Rates of Chronic Kidney, Cardiovascular Disease

Drug Topics

A study found that patients with type 2 diabetes who showed evidence of any remission had a 33% lower rate of chronic kidney disease, and a 40% lower rate of the composite cardiovascular disease measure.

210
210
article thumbnail

Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

STAT

WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional staff that he didn’t have the expertise to testify at a Senate hearing on prescription drug prices because he’s a tax attorney. Sanders, who has threatened to subpoena the CEOs of Merck and Johnson & Johnson over their refusal to testify at a hearing on why drug prices are higher in the United States than other countries, told reporters the reasons the companies gave ranged fro

145
145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Adds Boxed Warning to Denosumab for Increased Risk of Hypocalcemia in Patients With CKD

Pharmacy Times

According to the FDA review, patients with CKD receiving denosumab for osteoporosis who are on dialysis or have CKD-MBD are at the highest risk of severe hypocalcemia.

FDA 149
article thumbnail

Humana's stock tumbles pre-market as it posts $541M loss in Q4

Fierce Healthcare

Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss. | Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss.

138
138
article thumbnail

FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer Concern

Drug Topics

As per US law Section 505(o)(4), the manufacturers are required to make the requested changes, respond with a modified version of the requested changes for review, or respond with a rebuttal within 30 days of the FDA's ask.

FDA 199
article thumbnail

New chronic Covid study offers insight into which immunocompromised patients are most at risk

STAT

You’ve heard of long Covid, a condition in which the acute infection subsides but troubling symptoms persist. Less well known is chronic Covid: The virus just doesn’t leave, sometimes staying in patients’ bodies long enough to mutate into new variants. This happens to people whose immune systems are compromised, whether through disease or treatment, leaving them vulnerable to infections that last weeks, months, or, in one known case, a year.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Obstetrical Patient Dies After Inadvertent Administration of Digoxin for Spinal Anesthesia

Pharmacy Times

The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine

181
181
article thumbnail

Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff

Fierce Pharma

Even as Gilead looks to become an oncology powerhouse in the coming years, the company on Monday recorded a major setback for its antibody-drug conjugate (ADC) Trodelvy. | The antibody-drug conjugate did not significantly improve survival outcomes compared with a chemotherapy alone in previously treated patients with metastatic non-small cell lung cancer.

article thumbnail

City of Boston Sues Major PBMs Over Role in Opioid Crisis

Drug Topics

The lawsuit claims several pharmacy benefit managers, including Express Scripts and OptumRx, collaborated with manufacturers in “deceptive” and “dangerous” marketing.

189
189
article thumbnail

Abortion funds run short of money as demand soars and donations fall

STAT

The head of the Abortion Fund of Ohio had a sinking feeling as she looked at its end-of-year finances last month. The fund had paid out $1.5 million in 2023 to help close to 4,400 patients get abortions — up from 1,175 the year before — and the pace wasn’t sustainable. If the fund didn’t take a pause for a few weeks, she feared it would run out of money and have to close for good.

145
145
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Navigating Challenges in Hepatic Encephalopathy Treatment

Pharmacy Times

Jennifer Marsh, PharmD, BCCCP, discusses the current standard of care for hepatic encephalopathy, highlighting challenges in treatment, prescription drug coverage, transition of care, and outpatient treatment access.

132
132
article thumbnail

AI can crack open the 'black box' of effective mental health therapy at scale, study finds

Fierce Healthcare

As artificial intelligence advances in different areas of healthcare, there are concerns that technology and AI-based chatbots will replace the human connections between patients and practitioners. | A new study finds promising potential for AI and large language models to enhance mental health therapy at scale by being able to analyze millions of text-based counseling messages to shine a light on what works.

134
134
article thumbnail

Oral Simnotrelvir May Shorten Recovery Time of Patients With Mild-to-Moderate COVID-19

Drug Topics

Patients who received oral simnotrelvir recovered up to 1.5 days faster from COVID-19 compared to patients who received a placebo in the new study.

201
201
article thumbnail

Why many more people are lining up for a flu shot than a Covid vaccine

STAT

America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. Each new round of boosters has drawn fewer bared arms than the round before it. The Centers for Disease Control and Prevention estimates that, as of Jan. 6, a mere 21.5% of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine.

Vaccines 145
article thumbnail

Circadian Disruption May Be Significantly Linked to Chronic Kidney Disease

Pharmacy Times

Increased waist circumference and high blood pressure can disrupt circadian rhythm, which can increase risk of progression to poor renal outcomes.

139
139
article thumbnail

Pharma Horizons: Artificial Intelligence

European Pharmaceutical Review

The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceutical manufacturing and quality control. AI/ML is predicted to be the top technology investment for 60 percent of life sciences companies over the next two years, according to a recent survey 1 from the Pistoia Alliance.

130
130
article thumbnail

Dupilumab Approved by FDA to Treat Eosinophilic Esophagitis in Children Under 12

Drug Topics

Eosinophilic esophagitis is a chronic, progressive disease thought to be responsible for damaging the esophagus, and it can severely impact a child’s ability to eat.

FDA 185
article thumbnail

Rollout of a new malaria vaccine kicks off in Africa

STAT

LONDON — Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon — a day that global health officials say marked a historic step in the decades-long quest to protect people from one of the world’s deadliest infections. The vaccine drive in Cameroon — the first launch of the vaccine outside of clinical trials and pilot programs — comes as some 20 African countr

Vaccines 145
article thumbnail

Report: Oncology, Immunology Projected to Lead Global Spending From 2024 to 2028

Pharmacy Times

The IQVIA Global Use of Medicines report for 2024 predicts that loss of brand exclusivity will negatively impact global market growth.

145
145
article thumbnail

CMS seeks input on improving transparency in Medicare Advantage

Fierce Healthcare

The Centers for Medicare & Medicaid Services is seeking feedback on how to increase transparency around Medicare Advantage and improve data capabilities. | CMS initiated a request for information period Thursday to receive data on all aspects of the Medicare Advantage program including prior authorizations, value-based care and vertical integration.

130
130
article thumbnail

RSV Hospitalization Risk Higher than Flu, Omicron Among Children

Drug Topics

Of the 2596 patients included in the study, the hospitalization rates were 31.5% for Omicron, 27.7% for influenza, and 81.7% for RSV.

Hospitals 185
article thumbnail

Opinion: Defunding liberal arts is dangerous for health care

STAT

If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about the value of a liberal arts education has seemingly devolved into mortal combat, leaving the humanities in dire straits on college campuses. For example, the Atlantic recently reported on West Virginia University’s decision to gut its humanities programming, and the New York Times wondered whether the liberal arts will exist after the budget cuts hap

article thumbnail

Public Health Matters: A Review of Upcoming Digital Health Technology Products

Pharmacy Times

Public Health Pharmacist discussed wearable technology and AI assisted technology that was displayed at the 2024 Consumer Electronics Show

139
139
article thumbnail

Isaac Health nabs $5.7M seed round to scale up virtual brain health and dementia care

Fierce Healthcare

The U.S. faces a growing shortage of neurologists, creating care "deserts" around the country, forcing patients to wait longer and drive further to receive care. | Digital health company Isaac Health launched in 2022 to provide a virtual brain health and memory clinic platform with the goal of improving access to constrained brain health services.

133
133
article thumbnail

Merck's Keytruda extends life for kidney cancer patients after surgery, while Bristol's Opdivo fails again

Fierce Pharma

Merck’s unique approval for Keytruda as a postsurgical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives. | Merck’s unique approval for Keytruda as a postsurgerical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives.

129
129